The next-generation sequencing-based test is designed to capture all clinically relevant cystic fibrosis mutations in a single assay.
The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...
New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...
According to one of the authors, additional work is needed to validate findings in a larger prospective study ‘and to apply ...
In a breakthrough that redefines both speed and clinical potential, a new world record for the fastest human whole genome ...
PhD Defense: Detectie van pathogenen door middel van liquid biopsy shotgun sequencing ...
"Fueled by advances in NGS and precision medicine, China’s DNA sequencing market sees rapid growth amid strong government support, rising clinical applications, and innovation hubs in Guangdong, ...
Giovanna Prout joins Countable Labs as CEO to accelerate commercialization of Countable Labs’ products Countable Labs, the developer of Countable PCR, a category-defining PCR technology that sets a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback